News
ALPMY
16.30
-0.49%
-0.08
Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings
Seeking Alpha · 5h ago
Weekly Report: what happened at ALPMY last week (0330-0403)?
Weekly Report · 1d ago
ORIC Pharma drops after early-stage trial data for prostate cancer therapy
Seeking Alpha · 6d ago
Weekly Report: what happened at ALPMY last week (0323-0327)?
Weekly Report · 03/30 09:27
Jefferies Keeps Their Buy Rating on Astellas Pharma (ALPMF)
TipRanks · 03/24 10:19
J.P. Morgan Sticks to Its Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 03/23 10:16
Weekly Report: what happened at ALPMY last week (0316-0320)?
Weekly Report · 03/23 09:25
Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication
Seeking Alpha · 03/19 11:44
Astellas Pharma (ALPMF) Receives a Hold from Mizuho Securities
TipRanks · 03/19 10:16
CytomX Therapeutics: Still Some Ways To Go
Seeking Alpha · 03/17 18:07
Macquarie Reaffirms Their Buy Rating on Astellas Pharma (ALPMF)
TipRanks · 03/16 10:36
Weekly Report: what happened at ALPMY last week (0309-0313)?
Weekly Report · 03/16 09:25
Weekly Report: what happened at ALPMY last week (0302-0306)?
Weekly Report · 03/09 09:25
Weekly Report: what happened at ALPMY last week (0223-0227)?
Weekly Report · 03/02 09:25
Merck's Keytruda shows overall survival benefit in ovarian cancer
Seeking Alpha · 02/27 16:38
Merck, Pfizer Report Positive Results From Combined Bladder-Cancer Trial
Dow Jones · 02/27 15:28
Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX
NASDAQ · 02/27 14:17
Bayer says Xofigo/Xtandi combo shows overall survival benefit in prostate cancer
Seeking Alpha · 02/26 19:36
These Analysts Boost Their Forecasts On Vir Biotechnology
Benzinga · 02/24 18:05
What's Going On With Kyntra Bio Stock Tuesday?
Benzinga · 02/24 13:27
More
Webull provides a variety of real-time ALPMY stock news. You can receive the latest news about Astellas Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ALPMY
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.